Literature DB >> 12011553

Long-term prognosis of cerebral vein and dural sinus thrombosis. results of the VENOPORT study.

J M Ferro1, M G Lopes, M J Rosas, M A Ferro, J Fontes.   

Abstract

The purpose of this study was to analyze the long-term mortality, functional recovery and long-term complications of cerebral vein and dural sinus thrombosis (CVDST) admitted to Portuguese hospitals. A follow-up of symptomatic CVDST admitted to Portuguese hospitals since 1980 was performed. Fifty-one patients (retrospective cases) were re-evaluated during 1996; 91 consecutively admitted patients from 6/1995 to 6/1998 were followed up to 1999. In 1996, 4 (8%) of the retrospective cases had died (3 patients died in the acute phase), 4 (8%) could not be reached, 33 (64%) had recovered completely (Rankin 0 or 1) and 3 (6%) were dependent. The prospective cases had a mean follow-up of 1 year: 6 (7%) patients died in the acute phase, one (1%) died during follow-up, 75 (82%) recovered completely, and only 1 (1%) was dependent. For the prospective cases, worsening after admission (OR = 18.2; 95% CI = 2.9-112.4) and encephalopathy as the presenting syndrome (OR = 7.1; 95% CI = 1.2-40.9) predicted death or dependency, while absence of aphasia (OR 6.7, 95% CI = 1.6-33) and no worsening after admission (OR = 5.9; 95% CI = 1.6-20) predicted total recovery. During follow-up of the prospective cases, 4 (5%) patients had thrombotic events, 8 (10%) patients experienced seizures, 9 (11%) complained of severe headaches and 1 patient suffered severe visual loss. The long-term functional prognosis of patients with CVDST was fairly good with complete recovery in the majority of cases. However, these patients had a moderate risk of further thrombotic events and seizures. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 12011553     DOI: 10.1159/000057855

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  29 in total

Review 1.  [Current controversies in the diagnosis and management of cerebral venous and dural sinus thrombosis].

Authors:  S Schwarz; M Daffertshofer; T Schwarz; D Georgiadis; R W Baumgartner; M Hennerici; C Groden
Journal:  Nervenarzt       Date:  2003-08       Impact factor: 1.214

2.  Cerebral venous sinus thrombosis presenting in the puerperium.

Authors:  J Acheson; A Malik
Journal:  Emerg Med J       Date:  2006-07       Impact factor: 2.740

3.  Functional outcome after severe cerebral venous thrombosis.

Authors:  Andreas Bender; Gernot Schulte-Altedorneburg; Thomas E Mayer; Thomas Pfefferkorn; Tobias Birnbaum; Berend Feddersen; Hartmut Brückmann; Hans-Walter Pfister; Andreas Straube
Journal:  J Neurol       Date:  2007-03-31       Impact factor: 4.849

4.  Cerebral venous sinus thrombosis presenting in pregnancy and puerperium.

Authors:  Ganesh Dangal; Lok Bahadur Thapa
Journal:  BMJ Case Rep       Date:  2009-09-01

5.  Diagnostic imaging in the management of patients with possible cerebral venous thrombosis: a cost-effectiveness analysis.

Authors:  Dennis M Hedderich; José M Ferro; Wolfgang G Kunz
Journal:  Neuroradiology       Date:  2019-07-10       Impact factor: 2.804

6.  Treatment of progressive cerebral sinuses thrombosis with local thrombolysis.

Authors:  R Mohammadian; B Sohrabi; R Mansourizadeh; F Mohammadian; A Nazempour; M Farhoudi; A Pashapour; A A Taher Aghdam; A Hashemzadeh; M Pourkakrodi
Journal:  Interv Neuroradiol       Date:  2012-03-16       Impact factor: 1.610

Review 7.  Cerebral venous thrombosis: continental disparities.

Authors:  Laith Maali; Sheema Khan; Fares Qeadan; Mahmoud Ismail; Davana Ramaswamy; Vishnumurthy S Hedna
Journal:  Neurol Sci       Date:  2017-08-14       Impact factor: 3.307

8.  [Clinical course of cerebral sinus venous thrombosis. Data from a monocentric cohort study over 15 years].

Authors:  C Geisbüsch; C Lichy; D Richter; C Herweh; W Hacke; S Nagel
Journal:  Nervenarzt       Date:  2014-02       Impact factor: 1.214

Review 9.  Duration of anticoagulation after cerebral venous sinus thrombosis.

Authors:  Frances Caprio; Richard A Bernstein
Journal:  Neurocrit Care       Date:  2012-04       Impact factor: 3.210

Review 10.  Cerebral vein thrombosis.

Authors:  Francesco Dentali; Walter Ageno
Journal:  Intern Emerg Med       Date:  2009-12-01       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.